References with PepMix™ Peptide Pools - Tumor Associated Antigens



  • Videos of Sipuleucel-T Programmed T Cells Lysing Cells That Express Prostate Cancer Target Antigens
    Adam S Kibel et al., J Natl Cancer Inst. (2021) - PMID: 33630063
  • Functional T Cell Reactivity to Melanocyte Antigens Is Lost during the Progression of Malignant Melanoma, but Is Restored by Immunization
    Anna Przybyla et al., Cancers (Basel) (2021) - PMID: 33435427


  • Clinical Effects of Administering Leukemia-Specific Donor T Cells to Patients With AML/MDS Post-Allogeneic Transplant
    Premal Lulla et al., Blood (2020) - PMID: 33270816
  • Oncolytic Measles Virus Therapy Enhances Tumor Antigen-Specific T-Cell Responses in Patients With Multiple Myeloma
    Nandakumar Packiriswamy et al., Leukemia (2020) - PMID: 32327728
  • Pre-Transplant Assessment of pp65-Specific CD4 T Cell Responses Identifies CMV-Seropositive Patients Treated With rATG at Risk of Late Onset Infection
    Maria O.López-Oliva et al., Clinical Immunology (2020) - PMID: 31891764


  • Targeting Antigen to the Surface of EVs Improves the In Vivo Immunogenicity of Human and Non-human Adenoviral Vaccines in Mice
    Carly M. Bliss et al., Molecular Therapy: Methods & Clinical Development (2019) - PMID: 31934599
  • Evaluation of Newcastle Disease Virus Mediated Dendritic Cell Activation and Cross‐Priming Tumor‐Specific Immune Responses Ex Vivo
    Qi Xu et al., International Journal of Cancer (2019) - PMID: 31584185
  • Natural T Cell Autoreactivity to Melanoma Antigens: Clonally Expanded Melanoma-Antigen Specific CD8 + Memory T Cells Can be Detected in Healthy Humans
    Anna Przybyla et al., Cancer Immunology, Immunotherapy (2019) - PMID: 30783693
  • The Human CD4 T Cell Response Against Mumps Virus Targets a Broadly Recognized Nucleoprotein Epitope
    Jelle de Wit et al., Journal of Virology (2019) - PMID: 30626672
  • Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: a Mouse to Human Translational Study
    Erika J Crosby et al., Clinical Cancer Research (2019) - PMID: 30635338
  • Tel-eVax: a Genetic Vaccine Targeting Telomerase for Treatment of Canine Lymphoma
    Joseph A. Impellizeri et al., Journal of Translational Medicine (2018) - PMID: 30537967
  • Over-Expression of PD-1 Does Not Predict Leukemic Relapse After Allogeneic Stem Cell Transplantation
    Jain et al., Biology of Blood and Marrow Transplantation (2018) - PMID: n.a.
  • A Novel Allogeneic Off-The-Shelf Dendritic Cell Vaccine for Post-Remission Treatment of Elderly Patients with Acute Myeloid Leukemia
    Loosdrecht et al., Cancer Immunol Immunother. (2018) - PMID: 30039426
  • PRAME Peptide‐Specific CD8+ T Cells Represent the Predominant Response Against Leukemia‐Associated Antigens (LAAs) in Healthy Individuals
    Matko et al., European Journal of Immunology (2018) - PMID: 29738081
  • Combined IFN-γ and TNF-α Release Assay for Differentiating Active Tuberculosis from Latent Tuberculosis Infection
    Kim et al., Journal of Infection (2018) - PMID: 29746954
  • Personalized ex vivo Multiple Peptide Enrichment and Detection of T Cells Reactive to Multiple Tumor-associated Antigens in Prostate Cancer Patients
    Taborska et al., Med Oncol. (2017) - PMID: 28866803
  • An Immunogenic Personal Neoantigen Vaccine for Patients with Melanoma
    Ott et al., Nature (2017) - PMID: 28678778
  • Personalized RNA Mutanome Vaccines Mobilize Poly-specific Therapeutic Immunity Against Cancer
    Sahin et al., Nature (2017) - PMID: 28678784
  • Spontaneous CD4+ and CD8+ T Cell Responses Directed Against Cancer Testis Antigens are Present in the Peripheral Blood of Testicular Cancer Patients
    Pearce et al., European Journal of Immunology (2017) - PMID: 28555838
  • Generation of T Cell Effectors Using Tumor Cell-Loaded Dendritic Cells for Adoptive T Cell Therapy
    Vavrova et al., Medical Oncology (2016) - PMID: 27812850
  • A Phase I Study of Recombinant (r) Vaccinia-CEA (6D)-TRICOM and rFowlpox-CEA (6D)-TRICOM Vaccines with GM-CSF and IFN-α-2b in Patients with CEA-Expressing Carcinomas
    Duggan et al., Cancer Immunology, Immunotherapy (2016) - PMID: 27581603
  • Prognostic Impact of High Levels of Circulating Plasmacytoid Dendritic Cells in Breast Cancer
    Bailur et al., Journal of Translational Medicine (2016) - PMID: 27234566
  • Dysfunction of PSA-Specific CD8+ T Cells in Prostate Cancer Patients Correlates with CD38 and Tim-3 Expression
    Japp et al., Cancer Immunol Immunother. (2015) - PMID: 26289091
  • An HPV-E6/E7 Immunotherapy Plus PD-1 Checkpoint Inhibition Results in Tumor Regression and Reduction in PD-L1 Expression
    Rice et al., Cancer Gene Therapy (2015) - PMID: 26337747
  • Survivin-Specific CD4+ T Cells are Decreased in Patients with Survivin-Positive Myeloma
    Locke et al., J Immunother Cancer (2015) - PMID: 25992291
  • A Phase I Trial Combining Decitabine/dendritic Cell Vaccine Targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for Children with Relapsed or Therapy-Refractory Neuroblastoma and Sarcoma
    Krishnadas et al., Cancer Immunol Immunother. (2015) - PMID: 26105625
  • Guidelines For the Automated Evaluation of Elispot Assays
    Janetzki et al., Nature Protocols (2015) - PMID: 26110715
  • Functional Immunological Parameters Associated with Long-term Survival of Patients with Metastatic Melanoma
    Henning Zelba, Dissertation der Mathematisch-Naturwissenschaftlichen Fakultät der Eberhard Karls Universität Tübingen (2015) - PMID: n.a
  • Presence of Circulating Her-2-reactive CD8 + T-Cells is Associated with Lower Frequencies of Myeloid-derived Suppressor Cells and Regulatory T Cells, and Better Survival in Elderly Breast Cancer Patients
    Kini Bailur et al., Breast Cancer Research (2015) - PMID: n.a.
  • STAT3 Signaling Contributes to the High Effector Activities of Interleukin-15-derived Dendritic Cells
    Okada et al., Immunol Cell Biol. (2015) - PMID: 25582338
  • Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A-Specific T Cells
    Weide et al., Clin Cancer Res. (2014) - PMID: 24323899
  • Vaccines Against Antigens Involved in Therapy Resistance and Methods of Using Same
    Lyerly et al., US Patent 20,140,377,261 (2014) - PMID: n.a.
  • Establishment and Maintenance of a PBMC Repository for Functional Cellular Studies in Support of Clinical Vaccine Trials
    Sambor et al., J Immunol Methods. (2014) - PMID: 24787274
  • A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein-Barr virus (EBV) Target Antigens: a Phase I Trial in UK Patients with EBV-positive Cancer
    Taylor et al., Clinical Cancer Research (2014) - PMID: 25124688
  • Circulating CD4+ T Cells That Produce IL4 or IL17 When Stimulated by Melan-A but Not by NY-ESO-1 Have Negative Impacts on Survival of Patients with Stage IV Melanoma
    Zelba et al., Clin. Cancer Res. (2014) - PMID: 24938524
  • Common Ewing Sarcoma-Associated Antigens Fail to Induce Natural T Cell Responses in Both Patients and Healthy Individuals
    Altvater et al., Cancer Immunol Immunother. (2014) - PMID: 24973179
  • Intralesional Treatment of Stage III Metastatic Melanoma Patients with L19–IL2 Results in Sustained Clinical and Systemic Immunologic Responses
    Weide et al., Cancer Immunology. (2014) - PMID: 24906352
  • Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumor Lysate or Homogenate Combined with Immunomodulating Radiotherapy and/or Preleukapheresis IFN-α in Patients with Metastatic Melanoma: a Randomised “Proof-of principle” Phase II Study
    de Rosa et al., J Transl Med. (2014) - PMID: 25053129
  • Normalizing ELISPOT Responses to T-cell Counts: a Novel Approach for Quantification of HCMV-Specific CD4+ and CD8+ T-Cell Responses in Kidney Transplant Recipients
    Calarota et al., Journal of Clinical Virology (2014) - PMID: n.a.
  • Combination of Interleukin-12 gene Therapy, Metronomic Cyclophosphamide and DNA Cancer Vaccination Directs all Arms of the Immune System Towards Tumor Eradication
    Denies et al., Journal of Controlled Release (2014) - PMID:24887014
  • Decitabine Facilitates Immune Recognition of Sarcoma Cells by Upregulating CT Antigens, MHC molecules, and ICAM-1
    Krishnadas et al., Tumour Biol. (2014) - PMID: 24584817
  • T-Cell Responses after Haematopoietic Stem Cell Transplantation for Aggressive Relapsing-Remitting Multiple Sclerosis
    Burman et al., Immunology (2013) - PMID: 23721329
  • Lentivirus-Induced Dendritic Cells for Immunization Against High-Risk WT1+ Acute Myeloid Leukemia
    Sundarasetty et al., Hum Gene Ther. (2013) - PMID: 23311414
  • Generation of Multi-Leukemia Antigen-Specific T Cells to Enhance the Graft-Versus-Leukemia Effect After Allogeneic Stem Cell Transplant
    Weber et al., Natur Leukemia (2013) - PMID: 23528871
  • Generation of Tumor Antigen-Specific T Cell Lines from Pediatric Patients with Acute Lymphoblastic Leukemia—Implications for Immunotherapy
    Weber et al., Clin. Cancer Res. (2013) - PMID: 23838315
  • Induction of Tumoricidal Function in CD4+ T Cells is Associated with Concomitant Memory and Terminally Differentiated Phenotype
    Hirschhorn-Cymerman et al., J. Exp. Med. (2012) - PMID: 23008334
  • Three Sensitive Assays Do Not Provide Evidence for Circulating HuD-specific T cells in The Blood of Patients with Paraneoplastic Neurological Syndromes with Anti-Hu Antibodies
    de Jonste et al., Neuro Oncology. (2012) - PMID: 22591661
  • Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis
    Weide et al., J. Clin. Oncol. (2012) - PMID: 22529253
  • Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma
    Gerdemann et al., Molecular Therapy (2011) - PMID: 21915103
  • Improving T-Cell Therapy for Relapsed EBV-Negative Hodgkin Lymphoma by Targeting Upregulated MAGE-A4
    Cruz et al., Clin. Cancer Res. (2011) - PMID: 21908573
  • Prophylactic Transfer of BCR-ABL–, PR1-, and WT1-Reactive Donor T Cells after T cell–Depleted Allogeneic Hematopoietic Cell Transplantation in Patients with Chronic Myeloid Leukemia
    Bornhäuser et al., Blood. (2011) - PMID: 21540460
  • Induction of Complete and Molecular Remissions in Acute Myeloid Leukemia by Wilms’ Tumor 1 Antigen-Targeted Dendritic Cell Vaccination
    Tendeloo et al., PNAS (2010) - PMID: 20631300
  • Antigen-Specific Cytotoxic T Lymphocytes can Target Chemoresistant Side-Population Tumor Cells in Hodgkin’s Lymphoma
    Shafer et al., Leuk Lymphoma. (2010) - PMID: 20367572
  • High-Avidity Cytotoxic-T-lymphocytes Specific for a New Preferentially Expressed antigen of Melanoma (PRAME)-Derived Peptide can Target Leukemic- and Leukemic-precursor Cells
    Quintarelli et al., Blood (2010) - PMID: 21278353
  • MMP11: A Novel Target Antigen for Cancer Immunotherapy
    Peruzzi et al., Clin Cancer Res (2009) - PMID: 19509157
  • Induction of Wilms' Tumor Protein (WT1)-Specific Antitumor Immunity Using a truncated WT1-Expressing Adenovirus Vaccine
    Osada et al., Clin. Cancer Res. (2009) - PMID: 19351755
  • AtPTR1 and AtPTR5 Transport Sipeptides in Planta
    Komarova et al., Plant Physiology Preview (2008) - PMID: 18753286
  • The Wilms' Tumor Antigen is a Novel Target for Human CD4 Regulatory T Cells: Implications for Immunotherapy
    Lehe et al., Cancer Res. (2008) - PMID: 18676860
  • Three-Dimensional MR Mapping of Angiogenesis with 5 1(3)-targeted Theranostic Nanoparticles in the MDA-MB-435 Xenograft Mouse Model
    Schmieder et al., The FASEB Journal (2008) - PMID: 18697838
  • Complete Responses of Relapsed Lymphoma Following Genetic Modification of Tumor-Antigen Presenting Cells and T-lymphocyte Transfer
    Bollard et al., Blood (2007) - PMID: 17609424
  • An MVA Vaccine Overcomes Tolerance to Human p53 in Mice and Humans
    Song et al., Cancer Immunol Immunother (2007) - PMID: 17219151

Check our list of products, click and go.

Get a quote